|
06/06 - 01:47 PM ET
IMMUCOR: FDA ACCEPTS RESPONSE TO WARNING LETTER
|
|
|
|
|
|
|
06/04 - 04:06 PM ET
IMMUCOR SEES FYO9 REV OF $292M-$300M
|
06/04 - 04:06 PM ET
IMMUCOR SEES FYO9 EPS $1.11-$1.15
|
|
|
|
|
05/13 - 11:12 AM ET
IMMUCOR SHARES DOWN 5.1% TO $26.46; VOL. 1.25M VS 30-DAY AVG 794,148
|
05/13 - 11:12 AM ET
IMMUCOR: FDA HASN'T ORDERED PRODUCT RECALL OR LIMITED MANUFACTURE, DISTRIBUTION
|
05/13 - 11:11 AM ET
IMMUCOR SAYS WORKING DILIGENTLY TO RESPOND TO FDA AS SOON AS POSSIBLE
|
|
|
|
04/17 - 04:31 PM ET
Immucor Says Its CEO's Italian Trial Moves Toward Second Phase
|
|
|
|
04/02 - 10:41 AM ET
IMMUCOR GAINS 8.4% FOLLOWING 3Q RESULTS, OUTLOOK
|
|
04/02 - 09:05 AM ET
IMMUCOR SHARES JUMP 10.2% TO $26 IN PREMARKET
|
|
|
|
